These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36096996)

  • 1. Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: current challenges and strategies.
    Malhotra M; Shenoy S
    Transfus Apher Sci; 2022 Oct; 61(5):103554. PubMed ID: 36096996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.
    Shi PA; Luchsinger LL; Greally JM; Delaney CS
    Curr Opin Hematol; 2022 Nov; 29(6):317-326. PubMed ID: 36066376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
    Fitzhugh CD; Abraham A; Hsieh MM
    Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HLA in cord blood transplantation outcomes.
    Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
    HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
    Abraham A; Cluster A; Jacobsohn D; Delgado D; Hulbert ML; Kukadiya D; Murray L; Shenoy S
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1587-1592. PubMed ID: 28578010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplantation with omidubicel in sickle cell disease.
    Parikh S; Brochstein JA; Galamidi E; Schwarzbach A; Kurtzberg J
    Blood Adv; 2021 Feb; 5(3):843-852. PubMed ID: 33560399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
    Kassim AA; Sharma D
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
    Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
    Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
    Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.
    Fitzhugh CD; Abraham AA; Tisdale JF; Hsieh MM
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1171-85. PubMed ID: 25459186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
    Talano JA; Cairo MS
    Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical cord blood: an evolving stem cell source for sickle cell disease transplants.
    Shenoy S
    Stem Cells Transl Med; 2013 May; 2(5):337-40. PubMed ID: 23580541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
    Tanhehco YC; Bhatia M
    Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
    Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.